Legend Capital led a USD150m Series E for ClinChoice, a China- and US-based full-service clinical-stage contract research organization, with participation from Taikang Life Insurance and Sherpa Healthcare Partners, with follow-on from Apricot Capital and Lilly Asia Ventures. Read more